CSIMarket
 
Molecular Partners Ag  (NASDAQ: MOLN)
 

Molecular Partners Ag's Suppliers Performance

MOLN's Supply Chain




 
MOLN Costs vs Sales of Suppliers Growth

More on MOLN Suppliers






Molecular Partners Ag's Comment on Supply Chain


The company depends on single-source unaffiliated third-party suppliers for raw materials and other products required for manufacturing and formulating its product candidates. It also relies on third parties for filling, finishing, distribution, laboratory testing, and other manufacturing-related services. For its RDT, the company sources isotopes and utilizes third parties for radio-labeling and product supply. Disruptions or failures by these suppliers or service providers, caused by regulatory actions, financial difficulties, compliance issues, contamination, business interruptions, or labor disputes, could significantly impact the company's ability to supply product candidates. The company may face challenges in securing timely backup or alternative suppliers. Additionally, the development of product candidates in combination with other therapies introduces further risks related to regulatory approval and the supply of those therapies.

Molecular Partners Ag's Comment on Supply Chain


The company depends on single-source unaffiliated third-party suppliers for raw materials and other products required for manufacturing and formulating its product candidates. It also relies on third parties for filling, finishing, distribution, laboratory testing, and other manufacturing-related services. For its RDT, the company sources isotopes and utilizes third parties for radio-labeling and product supply. Disruptions or failures by these suppliers or service providers, caused by regulatory actions, financial difficulties, compliance issues, contamination, business interruptions, or labor disputes, could significantly impact the company's ability to supply product candidates. The company may face challenges in securing timely backup or alternative suppliers. Additionally, the development of product candidates in combination with other therapies introduces further risks related to regulatory approval and the supply of those therapies.







MOLN's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Molecular Partners Ag 148.71 4.97 -61.65 130
SUBTOTAL 0.00 0.00 0.00 -


Sources: Molecular Partners Ag's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Molecular Partners Ag’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.